Pharmacokinetics, Tolerability, and Bacteriological Response of Rifampin Administered at 600, 900, and 1,200 Milligrams Daily in Patients with Pulmonary Tuberculosis. [electronic resource]
Producer: 20180611ISSN:- 1098-6596
- Adult
- Antibiotics, Antitubercular -- administration & dosage
- Dose-Response Relationship, Drug
- Double-Blind Method
- Drug Therapy, Combination
- Ethambutol -- therapeutic use
- Female
- Humans
- Isoniazid -- therapeutic use
- Male
- Mycobacterium tuberculosis -- drug effects
- Pyrazinamide -- therapeutic use
- Rifampin -- administration & dosage
- Treatment Outcome
- Tuberculosis, Pulmonary -- drug therapy
No physical items for this record
Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.